| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/27/2010 | US7705128 Comprises interleukin-1 zeta polypeptides (IL-1) for diagnosis, prevention and treatment of tumors, allergies and infectious diseases |
| 04/27/2010 | US7705125 Botulinum neurotoxin type E having increased biological half-life for use treatment and prevention of autonomic, neuromuscular and pain disorders |
| 04/27/2010 | US7705124 Leucine-based motif and clostridial neurotoxins |
| 04/27/2010 | US7705123 Fusion protein contains antibody fragment, or Fc fragment; biodrug for use in the treatment and prevention of autoimmune and cancer diseases |
| 04/27/2010 | US7705121 Chimeric human T1R3 taste receptor polypeptides and compositions containing same |
| 04/27/2010 | US7704970 DNA vaccination for treatment of autoimmune disease |
| 04/27/2010 | US7704969 Transfection complexes |
| 04/27/2010 | US7704968 treating cancer with antisense oligonucleotide complementary to a region of a nuclear factor- kappa B(NF- kappa B) subunit mRNA, contains phosphate backbone chemically modified; leukemia, fibroblast cancer; inhibiting septic shock; biocompatibility with no side effect |
| 04/27/2010 | US7704965 Methods and materials for treating human papillomavirus infections |
| 04/27/2010 | US7704964 Methods and compounds for the targeting of protein to exosomes |
| 04/27/2010 | US7704963 Administering as antitumor or anticarcinogenic agent; interference RNA |
| 04/27/2010 | US7704962 Small oligonucleotides with anti-tumor activity |
| 04/27/2010 | US7704954 Method and carrier complexes for delivering molecules to cells |
| 04/27/2010 | US7704952 treating diabetes or obesity using isolated polypeptide is covalently modified with a water-soluble polymer |
| 04/27/2010 | US7704945 First fusion polypeptide is linked to a second fusion polypeptide via disulfide bond between the heavy chain and light chain polypeptide, where in the first polypeptide binds interleukin-18 |
| 04/27/2010 | US7704925 Ligational encoding using building block oligonucleotides |
| 04/27/2010 | US7704743 Electrosonic cell manipulation device and method of use thereof |
| 04/27/2010 | US7704742 Method and polynucleotides for determining translational efficiency of a codon |
| 04/27/2010 | US7704736 Compositions for the derivation of germ cells from stem cells and methods of use thereof |
| 04/27/2010 | US7704727 chamber which comprises at least one inlet line comprising at least one opening arranged close to said electrode; due to this specific arrangement the inner space of said chamber can be effectively rinsed, even in a closed state and under aseptic conditions |
| 04/27/2010 | US7704725 for the production of macrolides such as Tacrolimus, sirolimus |
| 04/27/2010 | US7704724 Catalytic buffering systems |
| 04/27/2010 | US7704722 Suppressing induction of transcription of cloned DNA in bacterial cells grown batchwise; glucose inhibition of transgenic promoters |
| 04/27/2010 | US7704720 Propagating viral RNA sequences in host cells for use as tools in developing vaccines against viral infection; genetic vaccines; immunotherapy |
| 04/27/2010 | US7704719 genetic and protein engineered thermoanaerobacterium saccharolyticum glucose isomerase, provides a series of glucose isomerases with improved thermostability catalytic activity suitable for the production of high fructose corn syrup containing high concentration of fructose |
| 04/27/2010 | US7704717 Plant caffeic acid-3-O-methyltransferase homologs |
| 04/27/2010 | US7704716 Geraniol synthase, methods of production and uses thereof |
| 04/27/2010 | US7704715 Polymorphic monooxygenase comprising mutation in heme domain of a secondary structural element and enhanced heat stability; improved peroxide-driven hydroxylation |
| 04/27/2010 | US7704713 Polypeptides having DNA polymerase activity |
| 04/27/2010 | US7704712 DNA polymerase fusions and uses thereof |
| 04/27/2010 | US7704710 Expression vectors; transformed host cells; culturing the host cell to produce the encoded polypeptide; antiasthmatic agents |
| 04/27/2010 | US7704709 Recombinant cytokine protein for use in treatment of leukemia |
| 04/27/2010 | US7704698 Human T2R51 taste receptor and related assays for identifying bitter taste modulators |
| 04/27/2010 | US7704694 Using internal transcribe spacer as screening tool in detection of glycine species in food products |
| 04/27/2010 | US7704689 Method for generating hypermutable plants |
| 04/27/2010 | US7704688 Using RNA interference to prevent and treat viral diseases |
| 04/27/2010 | US7704686 Methods of identifying immunoregulatory agents, immunoregulatory agents, and uses thereof |
| 04/27/2010 | US7704685 In vivo production of a clostridial neurotoxin light chain peptide |
| 04/27/2010 | US7704513 Nucleic acids and polypeptides specific for pathogenic strains of the Neisseria genus |
| 04/27/2010 | US7704509 Producing an infectious, self-replicating, recombinant human parainfluenza viral particle for use in developing vaccine or preventative against respiratory tract infections |
| 04/27/2010 | US7704506 Fcε-PE chimeric protein for targeted treatment of allergy responses a method for its production and pharmaceutical compositions containing the same |
| 04/27/2010 | US7704505 preventing a respiratory syncytial virus (RSV) infection which is MAb1129 by administering to a human in need thereof an effective amount of a humanized anti-RSV antibody which contains the one CDR from each variable heavy and variable light chain of at least one murine monoclonal antibody |
| 04/27/2010 | US7704501 Antibodies binding to human ataxin-1-like polypeptide |
| 04/27/2010 | US7704500 Fusion polypeptide capable of binding vascular endothelial growth factor (VEGF), wherein polypeptide consists of immunoglobulin-like (Ig) domain 2 of a first VEGF receptor and Ig domain 3 of a second VEGF receptor and multimerizing component; use in decreasing or inhibiting plasma leakage; eye disorders |
| 04/27/2010 | US7704498 Antiproliferative agents; anticancer agents; composition comprising antagonist of a human ErbB4 receptor, in admixture with a pharmaceutically acceptable carrier; antagonist selected from group consisting of an antibody produced by a hybridoma selected from the group containing HER4.10H1.1A1 |
| 04/27/2010 | US7704497 Molecules with extended half-lives, compositions and uses thereof |
| 04/27/2010 | US7704496 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis |
| 04/27/2010 | US7704492 providing recombinant adeno-associated virus (AAV) virion which comprises an AAV vector, AAV vector comprising selected gene operably linked to control elements capable of directing in vivo transcription and translation of selected gene and introducing recombinant AAV virion into muscle cell or tissue |
| 04/27/2010 | US7704491 Recombinant human metapneumovirus and its use |
| 04/27/2010 | US7704363 microfluidics; electrophoresis; microfluidics |
| 04/27/2010 | US7704272 Method for introducing an ultraviolet light activated viral vector into the spinal column |
| 04/27/2010 | CA2413857C Pd-l2 molecules: pd-1 ligands and uses therefor |
| 04/27/2010 | CA2400570C Heterologous expression of neisserial proteins |
| 04/27/2010 | CA2387306C Assays for short sequence variants |
| 04/27/2010 | CA2374377C Potassium channel kcnq5 |
| 04/27/2010 | CA2372698C Microarray-based subtractive hybridization |
| 04/27/2010 | CA2372400C Expression and export of interferon-alpha proteins as fc fusion proteins |
| 04/27/2010 | CA2371816C Phthalamide-lanthanide complexes for use as luminescent markers |
| 04/27/2010 | CA2328431C Plasmin inhibitors from the australian brown snake pseudonaja textilis textilis |
| 04/27/2010 | CA2324978C Method, reagent and kit for genotyping of human papillomavirus |
| 04/27/2010 | CA2323776C Cytokine receptor common gamma chain like |
| 04/27/2010 | CA2303202C Amino acid sequences for therapeutical and prophylactic applications to diseases due to clostridium difficile toxins |
| 04/27/2010 | CA2297660C Production of human mutated proteins in human cells by means of homologous recombination |
| 04/27/2010 | CA2293692C Methods and reagents for vaccination which generate a cd8 t cell immune response |
| 04/27/2010 | CA2289907C Eukaryotic and retroviral antisense initiator elements |
| 04/27/2010 | CA2279844C Plant pyruvate dehydrogenase kinase gene |
| 04/27/2010 | CA2278465C Diagnosis and treatment of myocardial failure |
| 04/27/2010 | CA2222129C A method for producing influenza hemagglutinin multivalent vaccines |
| 04/27/2010 | CA2210242C Production of enzymatically active recombinant carboxypeptidase b |
| 04/27/2010 | CA2195653C Cells bearing cd4 decoy receptors and related molecules and methods |
| 04/27/2010 | CA2192159C Nucleic acid sequences and expression systems for heparinase ii and heparinase iii derived from flavobacterium heparinum |
| 04/27/2010 | CA2179909C Ligand that binds fas antigen |
| 04/27/2010 | CA2162353C Interferon-.gamma. production inducing polypeptide, monoclonal antibody, and agent for interferon-.gamma. susceptive disease |
| 04/22/2010 | WO2010045659A1 Safe lentiviral vectors for targeted delivery of multiple therapeutic molecules |
| 04/22/2010 | WO2010045629A2 Production of c5-c8 alcohols using evolved enzymes and metabolically engineered microorganisms |
| 04/22/2010 | WO2010045617A2 Detecting genetic abnormalities |
| 04/22/2010 | WO2010045561A2 Glutamate receptors as regulators of carbon transport, mobilization, distribution, reallocation and partitioning in higher plants |
| 04/22/2010 | WO2010045526A1 Geminin inhibitors as tumor treatment |
| 04/22/2010 | WO2010045512A2 Processes and compositions for liposomal and efficient delivery of gene silencing therapeutics |
| 04/22/2010 | WO2010045469A2 Muc18 targeting peptides |
| 04/22/2010 | WO2010045384A2 Short hairpin rnas for inhibition of gene expression |
| 04/22/2010 | WO2010045324A1 Utilization of fatty acid desaturases from hemiselmis spp. |
| 04/22/2010 | WO2010045318A2 Gene and gene expressed protein targets depicting biomarker patterns and signature sets by tumor type |
| 04/22/2010 | WO2010045218A1 Molecular clock mechanism of hybrid vigor |
| 04/22/2010 | WO2010045211A2 Genetic loci associated with northern leaf blight resistance in maize |
| 04/22/2010 | WO2010045002A2 Gene therapy vectors and cytosine deaminases |
| 04/22/2010 | WO2010044923A1 Methods for haplotype determination by haplodissection |
| 04/22/2010 | WO2010044894A1 Methods and compositions for treatment of myotonic dystrophy |
| 04/22/2010 | WO2010044786A1 Modified variant bowman birk protease inhibitors |
| 04/22/2010 | WO2010044603A1 Cellulase-producing trametes hirsuta and its use for saccharification |
| 04/22/2010 | WO2010044481A1 Biological rhythm prediction method |
| 04/22/2010 | WO2010044468A1 Construction and crystallization of expression system for rna polymerase pb1-pb2 protein derived from influenza virus |
| 04/22/2010 | WO2010044464A1 Modified amyloid beta peptide |
| 04/22/2010 | WO2010044459A1 Method for predicting risk of glaucoma |
| 04/22/2010 | WO2010044450A1 Transgenic plant of which seed has enlarged size |
| 04/22/2010 | WO2010044395A1 Method for introducing gene into cell, and composition for use in the method |
| 04/22/2010 | WO2010043928A1 Derived proteins from cry genes of bacillus thuringiensis |
| 04/22/2010 | WO2010043630A2 A delivery system for rna |
| 04/22/2010 | WO2010043582A1 Method for the treatment of cancer |
| 04/22/2010 | WO2010043271A1 Device, kit and method for pulsing biological samples with an agent and stabilising the sample so pulsed |